Simple Synthesis of a Heterocyclophane Exhibiting Anti‐c‐Met Activity by Acting as a Hatch Blocking Access to the Active SiteAugust 26, 2020
SilcsBio and Dalriada Drug Discovery Launch Partnership to Create a Rapid Drug Discovery Service SuiteJune 11, 2020SilcsBio and Dalriada Drug Discovery Launch Partnership to Create a Rapid Drug Discovery Service Suite SilcsBio and Dalriada to tap areas of expertise in drug design and development to accelerate clients’ programs in development of therapeutic...
Structure-Based Optimization of 10-DEBC Derivatives as Potent and Selective Pim-1 Kinase InhibitorsMay 20, 2020
Impact of Electronic Polarizability on Protein-Functional Group InteractionsMay 15, 2020
Identification and characterization of fragment binding sites for allosteric ligand design using the site identification by ligand competitive saturation hotspots approach (SILCS-Hotspots)January 28, 2020
GEn1E Lifesciences, a Y Combinator-Backed Company, Granted Exclusive License for University of Maryland, Baltimore Drug Portfolio CompoundDecember 3, 2019GEn1E Lifesciences, a Y Combinator-Backed Company, Granted Exclusive License for University of Maryland, Baltimore Drug Portfolio Compound Tuesday, December 3, 2019 PALO ALTO, Calif. and BALTIMORE, Dec. 3, 2019 /PRNewswire/ — GEn1E...
Exploring protein‐protein interactions using the site‐identification by ligand competitive saturation methodologyNovember 15, 2019
Pharmacophore Modeling Using Site-Identification by Ligand Competitive Saturation (SILCS) with Multiple Probe Molecules
Second harmonic generation detection of Ras conformational changes and discovery of a small molecule binderSeptember 18, 2019